RecruitingNot ApplicableNCT06099743

ASCENT Intervention for Brain Tumor Patients

An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors


Sponsor

Massachusetts General Hospital

Enrollment

100 participants

Start Date

May 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18
  • Massachusetts General Hospital Cancer Center Patient
  • Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
  • English speaking

Exclusion Criteria3

  • Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
  • Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale \< 8)
  • Current or imminent hospice enrollment

Interventions

BEHAVIORALPsychosocial intervention

Intervention manual and six one-on-one coaching sessions.

OTHERUsual supportive care

Referral to cancer center supportive care services (e.g., social work) as needed, upon request from the patient, caregiver, or clinician.


Locations(1)

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06099743


Related Trials